<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04115137</url>
  </required_header>
  <id_info>
    <org_study_id>GITMI-05</org_study_id>
    <nct_id>NCT04115137</nct_id>
  </id_info>
  <brief_title>Pelvic Varicose Veins Treated With Vascular Plugs Type Amplatzer: REPiVAC</brief_title>
  <acronym>REPiVAC</acronym>
  <official_title>Multicentric Spanish Record of Pelvic Varicose Veins Treated With Vascular Plugs Type Amplatzer - Pelvic Congestion Syndrome: Study of Efficacy and Safety</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Group of Research in Minimally Invasive Techniques</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Group of Research in Minimally Invasive Techniques</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spanish multicentric record to study the efficacy and safety of the treatment with plugs in
      Pelvic Congestion Syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an prospective observational study of patients that have been treated with plugs
      (type Amplazer) at least one of the pelvic varicose veins.

      Patients are recruited when the plug is implanted, and the investigators perfom a patients
      follow-up during 1, 3, 6, 12, 24 months
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">January 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Embolization of pelvic varicose veins using AVP</measure>
    <time_frame>24 months</time_frame>
    <description>39/5000 absence of symptoms and vaginal ultrasound</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Pelvic Congestion Syndrome</condition>
  <condition>Pelvic Varicose Veins</condition>
  <condition>Follow-up Study</condition>
  <condition>Embolization, Therapeutic</condition>
  <condition>Observational Study</condition>
  <arm_group>
    <arm_group_label>Women with pelvic congestion syndrome</arm_group_label>
    <description>Women older than 18 years At least 1 birth Present symptoms</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>pelvic varicose veins plug embolization</intervention_name>
    <description>pelvic varicose veins plug embolization</description>
    <arm_group_label>Women with pelvic congestion syndrome</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women older than 18 years , minimun 1 bith and with symptoms of pelvic congestion syndrome
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female &lt; 18 years

          -  Present symptomatology

          -  At least one image diagnosis

        Exclusion Criteria:

          -  Female &gt; 18

          -  Non present symptomatology

          -  Non diagnosis
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Women older than 18, minimun 1 bith</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miguel A De Gregorio, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Minimal Invasive Techniques Research Group</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Miguel A De Gregorio, Ph.D.</last_name>
    <phone>+34976765768</phone>
    <email>mgregori@unizar.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jos√© A Guirola, M.D.</last_name>
    <phone>+34976556400</phone>
    <phone_ext>162984</phone_ext>
    <email>joseandresguirola@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lozano Blesa Universitary Hospital</name>
      <address>
        <city>Zaragoza</city>
        <state>Aragon</state>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Angel De Gregorio, Phd</last_name>
      <phone>34976765768</phone>
      <email>mgregori@unizar.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Vithas Nisa Pardo de Aravaca</name>
      <address>
        <city>Madrid</city>
        <zip>28023</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Urbano, M.D</last_name>
      <phone>34 915 12 90 00</phone>
      <email>jurbano34@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>July 11, 2019</study_first_submitted>
  <study_first_submitted_qc>October 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 3, 2019</study_first_posted>
  <last_update_submitted>October 2, 2019</last_update_submitted>
  <last_update_submitted_qc>October 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pelvic Congestion Syndrome</keyword>
  <keyword>amplatzer vascular plug</keyword>
  <keyword>Vascular plug</keyword>
  <keyword>metallic embolization device</keyword>
  <keyword>Chronic pelvic pain</keyword>
  <keyword>embolization procedure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Veins</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

